Here are the DEF 14A proxy statements from Context Therapeutics Inc. (CNTX) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow CNTX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CNTX filings page.
Context Therapeutics Inc. is asking stockholders to vote at its virtual 2026 annual meeting on June 24, 2026 at 8:00 a.m. Eastern Time. Stockholders of record as of April 27, 2026, when 91,879,177 common shares were outstanding, may vote online or by proxy.
Investors are asked to elect seven directors for one-year terms, ratify CohnReznick LLP as independent auditor for 2026, and approve a charter amendment increasing authorized common stock from 200,000,000 to 300,000,000 shares to preserve flexibility for future financing, compensation and strategic uses. A separate proposal would allow adjournment of the meeting to solicit more proxies, particularly for the share increase, or to reach the 33 1/3% quorum required by Nasdaq rules.
The proxy statement also details board committee structures, independence determinations, risk oversight, insider trading and anti-hedging policies, and the background of directors and executive officers.